| RS1351590882 |
CUX2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 67 |
| RS1351604858 |
NSUN2
|
Health Risk |
Likely pathogenic |
— |
| RS1351633854 |
ARID1B
|
Health Risk |
Pathogenic |
— |
| RS1351636899 |
GALE
|
Health Risk |
Pathogenic |
UDPglucose-4-epimerase deficiency, UDPglucose-4-epimerase deficiency |
| RS1351645436 |
KAT6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Genitopatellar syndrome, Genitopatellar syndrome |
| RS1351649810 |
ASNS
|
Health Risk |
Pathogenic |
— |
| RS1351655525 |
FYN
|
Health Risk |
Pathogenic |
EBV-positive nodal T- and NK-cell lymphoma, EBV-positive nodal T- and NK-cell lymphoma |
| RS1351661862 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1351664704 |
RNF13
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1351673148 |
MMAB
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblB type |
| RS1351675410 |
F9
|
Health Risk |
Pathogenic |
— |
| RS1351684695 |
MYH3
|
Health Risk |
Pathogenic |
— |
| RS1351692845 |
SLC19A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Megaloblastic anemia, thiamine-responsive |
| RS1351698030 |
LARP7
|
Health Risk |
Pathogenic |
— |
| RS1351701416 |
PRRT2
|
Health Risk |
Pathogenic |
Episodic kinesigenic dyskinesia, Episodic kinesigenic dyskinesia |
| RS1351702441 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1351703532 |
CIB1
|
Health Risk |
risk factor |
Epidermodysplasia verruciformis, susceptibility to |
| RS1351742344 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1351747266 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1351749039 |
PI4KA
|
Health Risk |
Likely pathogenic |
Polymicrogyria, perisylvian |
| RS1351753257 |
WT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Drash syndrome, Hereditary cancer-predisposing syndrome |
| RS1351772557 |
TEX15
|
Health Risk |
Pathogenic |
Non-obstructive azoospermia, Non-obstructive azoospermia |
| RS1351781261 |
COL4A3
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS1351809843 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS1351862780 |
COG7
|
Health Risk |
Conflicting classifications of pathogenicity |
COG7 congenital disorder of glycosylation, COG7 congenital disorder of glycosylation |
| RS1351871440 |
GRM6
|
Health Risk |
Pathogenic |
— |
| RS1351875080 |
TRMU
|
Health Risk |
Likely pathogenic |
— |
| RS1351891195 |
CFH
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1351910038 |
ARID1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1351915127 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Myofibrillar myopathy 5 |
| RS1351918391 |
PKHD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 4, Autosomal recessive polycystic kidney disease |
| RS1351926905 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1351956022 |
CACNA1S
|
Health Risk |
Pathogenic |
Malignant hyperthermia, susceptibility to |
| RS1351971341 |
AAAS
|
Health Risk |
Likely pathogenic |
— |
| RS1351976589 |
ACADVL
|
Health Risk |
Conflicting classifications of pathogenicity |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1351986946 |
BAP1
|
Health Risk |
Pathogenic |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1351993448 |
NLRP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Chronic infantile neurological, cutaneous and articular syndrome |
| RS1352006092 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1352006130 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS1352007983 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinitis pigmentosa 39 |
| RS1352009139 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1352009961 |
POR
|
Health Risk |
Likely pathogenic |
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis |
| RS1352010373 |
TMEM94
|
Health Risk |
Pathogenic |
TMEM94-related disorder, Intellectual developmental disorder with cardiac defects and dysmorphic facies |
| RS1352019198 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1352024223 |
SCN8A
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, SCN8A-related disorder |
| RS1352066127 |
SGSH
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-A |
| RS1352070054 |
SPG11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS1352100383 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Inborn genetic diseases |
| RS1352107832 |
NCF2
|
Health Risk |
Likely pathogenic |
Granulomatous disease, chronic |
| RS1352133982 |
GALNT3
|
Health Risk |
Pathogenic |
— |
| RS1352135631 |
SGCA
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS1352149832 |
POMGNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1352161022 |
ANKS6
|
Health Risk |
Pathogenic |
Nephronophthisis 16, Nephronophthisis 16 |
| RS1352162269 |
GALNS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS1352171735 |
VHL
|
Health Risk |
Conflicting classifications of pathogenicity |
Chuvash polycythemia, Von Hippel-Lindau syndrome |
| RS1352191146 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS1352193481 |
HGSNAT
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS1352205875 |
SLC45A2
|
Health Risk |
Likely pathogenic |
— |
| RS1352220583 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1352235060 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS1352237419 |
PRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 4 |
| RS1352258641 |
TET2
|
Health Risk |
Pathogenic |
Angioimmunoblastic T-cell lymphoma, Angioimmunoblastic T-cell lymphoma |
| RS1352259738 |
DNMT3A
|
Health Risk |
Pathogenic |
Intellectual disability, Tatton-Brown-Rahman overgrowth syndrome |
| RS1352275281 |
VHL
|
Health Risk |
Pathogenic/Likely pathogenic |
Von Hippel-Lindau syndrome, Chuvash polycythemia |
| RS1352310924 |
COQ4
|
Health Risk |
Pathogenic |
Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome, Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome |
| RS1352316880 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1352349454 |
RINT1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1352354716 |
NPHS1
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, Nephrotic syndrome |
| RS1352380841 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1352385210 |
RAD21
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 4, Cornelia de Lange syndrome 4 |
| RS1352390503 |
TTC8
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 51, Retinitis pigmentosa 51 |
| RS1352402588 |
FANCD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Ovarian cancer |
| RS1352407748 |
AHI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Inborn genetic diseases |
| RS1352409938 |
SPTAN1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1352416909 |
NAGLU
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS1352458826 |
CNGB1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS1352478541 |
FBN1
|
Health Risk |
Pathogenic/Likely pathogenic |
FBN1-related disorder, Marfan syndrome |
| RS1352483031 |
PLA2G6
|
Health Risk |
Pathogenic |
PLA2G6-associated neurodegeneration, PLA2G6-associated neurodegeneration |
| RS1352485089 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS1352510294 |
FLNB
|
Health Risk |
Pathogenic |
— |
| RS1352520437 |
MCM3AP
|
Health Risk |
Pathogenic |
— |
| RS1352532055 |
LAMB1
|
Health Risk |
Likely pathogenic |
— |
| RS1352544800 |
CELA2A
|
Health Risk |
Pathogenic |
Coronary artery disorder, Diabetes |
| RS1352552140 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1352584474 |
LAMP2
|
Health Risk |
Likely pathogenic |
Danon disease, Danon disease |
| RS1352586389 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1352606118 |
MCCC2
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS1352624446 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS1352631535 |
AMT
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy 2 |
| RS1352639242 |
ANKRD11
|
Health Risk |
Pathogenic |
— |
| RS1352644449 |
CREBBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Rubinstein-Taybi syndrome |
| RS1352655452 |
TRMT1
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder, autosomal recessive 68 |
| RS1352665263 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS1352698710 |
CHRND
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal multiple pterygium syndrome, Lethal multiple pterygium syndrome |
| RS1352726114 |
FERRY3
|
Health Risk |
Pathogenic |
— |
| RS1352740721 |
TECPR2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS1352744778 |
C19orf12
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodegeneration with brain iron accumulation 4, Hereditary spastic paraplegia 43 |
| RS1352756438 |
SDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Pheochromocytoma/paraganglioma syndrome 5, Mitochondrial complex II deficiency |
| RS1352765609 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS1352786910 |
HEXB
|
Health Risk |
Likely pathogenic |
Sandhoff disease, Sandhoff disease |